Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Hemophilia A Treatment Study

Clinical Trial Title: 
Prospective, open-label multicenter phase 3b to assess the efficacy and safety of personalized prophylaxis with Human-cl rh-FVIII in previously treated adult with severe hemophilia A.
Clinical Trial Protocol ID: 
14120110
Clinical Trial Investigator Name: 
Lisa Boggio, MD
Clinical Trial Protocol Description: 

Prophylaxis infusion with PK studies.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have severe hemophilia A.
  • Are male and at least 18 years of age.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Lisa Boggio, MD